| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 23.667 | 47.656 | 10.605 | 0 | 0 |
| Total Income - EUR | - | - | - | - | - | 32.475 | 47.656 | 10.605 | 0 | 0 |
| Total Expenses - EUR | - | - | - | - | - | 17.616 | 21.628 | 39.551 | 3.036 | 0 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 14.859 | 26.028 | -28.946 | -3.036 | 0 |
| Net Profit/Loss - EUR | - | - | - | - | - | 14.149 | 24.836 | -29.052 | -3.036 | 0 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Carm Theron Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 14.900 | 42.945 | 12.057 | 6.714 | 6.677 |
| Inventories | - | - | - | - | - | 0 | 20.582 | 3.046 | 0 | 0 |
| Receivables | - | - | - | - | - | 10.276 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | - | - | 4.624 | 22.363 | 9.012 | 6.714 | 6.677 |
| Shareholders Funds | - | - | - | - | - | 14.190 | 38.711 | 9.780 | 6.714 | 6.677 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 710 | 4.233 | 2.277 | 0 | 0 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1011 - 1011" | |||||||||
| CAEN Financial Year |
1011
|
|||||||||
Comments - Carm Theron Bio S.r.l.